North America Enteral Nutrition Market Forecast to 2030
North America Enteral Nutrition Market Forecast to 2030 – Regional Analysis – by Product Type (General and Disease Specific), Application (Gastrointestinal Disorders, Metabolic/Inborn Errors of Metabolism, Food Allergy, Renal Disease, Liver Disease, Oncology, Neurology, and Others), Age Group (Adult and Pediatric), and Distribution Channel (Hospital Pharmacies, Retail Stores, E-Commerce, and Others)
$2,840 – $4,440
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Increasing Prevalence of Gastrointestinal Diseases Fuel North America Enteral Nutrition Market
Gastrointestinal diseases include Crohn’s disease, bowel obstruction, ulcerative colitis, short bowel syndrome, microscopic colitis, and certain cancer types. As per the Global Burden of Disease Study 2019, ~4.9 million cases of inflammatory bowel disease (IBD) were recorded worldwide in 2019; the US (762,890) had the highest number of cases, with prevalence of 66.9 and 245.3 cases per 100,000 people, respectively. Crohn’s disease is a complex, chronic disorder primarily affecting the digestive system. Moreover, short bowel syndrome (SBS) occurs in ~3 per 1 million people yearly. As per the article titled “Understanding Short Bowel Syndrome: Current Status and Future Perspectives,” published in 2020, the prevalence of SBS has increased by more than twofold in the last 40 years. The prevalence of SBS was ~300 cases per 10 million in the US.
Patients with gastrointestinal diseases are at an elevated risk of nutritional deterioration as they are asked to fast before undergoing diagnostic tests. They may also face nutritional deterioration due to therapeutic dietary restriction and loss of appetite caused by anorexia or altered nutritional requirements, which can be a result of the disease itself. Thus, medical nutrition is recommended for these patients due to their inability to ingest food. Enteral routes are preferred to provide them with essential nutrients. Enteral feeding refers to the direct intake of food nutrients through the mouth or through a tube that passes the digestive tract (mouth to stomach/small intestine and then anus). This type of nutrition is preferred to provide treatment support for patients suffering from chronic ailments, such as neurological disorders, gastrointestinal diseases, and inherited metabolic diseases. Therefore, the surging prevalence of gastrointestinal diseases drives the growth of the enteral nutrition market.
North America Enteral Nutrition Market Overview
The North America enteral nutrition market is segmented into the US, Canada, and Mexico. North America accounts for a significant market share owing to the rising prevalence of chronic diseases, growing strategic developments by market players, and increasing preference for enteral nutrition contribute to the market progress in this region. Moreover, an upsurge in knowledge among individuals about the benefits of medical nutrition, such as tube feeding, in the treatment of chronic health conditions are anticipated to boost the North America enteral nutrition market growth during the forecast period.
Chronic diseases, such as cancer and heart disease, are the major causes of disability and death in the US. Per the National Center for Chronic Disease Prevention and Health Promotion, 6 in 10 people in the country have at least one chronic disease. Additionally, the American Hospital Association estimates ~133 million people have at least one chronic disease, and that number is expected to reach 170 million by 2030. Enteral tube feeding can be prescribed for treating more than 350 disease conditions in children.
North America Enteral Nutrition Market Revenue and Forecast to 2030 (US$ Million)
North America Enteral Nutrition Market Segmentation
The North America enteral nutrition market is segmented based on product type, application, age group, distribution channel, and country.
Based on product type, the North America enteral nutrition market is bifurcated into general and disease specific. The general segment held a larger North America enteral nutrition market share in 2022.
In terms of application, the North America enteral nutrition market is segmented into gastrointestinal disorders, metabolic/inborn errors of metabolism, food allergy, renal disease, liver disease, oncology, neurology, and others. The gastrointestinal disorders segment held the largest North America enteral nutrition market share in 2022.
Based on age group, the North America enteral nutrition market is bifurcated into adult and pediatric. The adult segment held a larger North America enteral nutrition market share in 2022.
By distribution channel, the North America enteral nutrition market is segmented into hospital pharmacies, retail stores, e-commerce, and others. The hospital pharmacies segment held the largest North America enteral nutrition market share in 2022.
Based on country, the North America enteral nutrition market is categorized into the US, Canada, and Mexico. The US dominated the North America enteral nutrition market in 2022.
Abbott Laboratories, Nestle SA, Danone SA, Fresenius SE & Co KGaA, B Braun SE, Dr Schar AG, Reckitt Benckiser Group Plc, Nutritional Medicinals LLC, Kate Farms Inc, Royal FrieslandCampina NV, Arla Foods amba, Perrigo Co Plc, and Fonterra Co-Operative Group Ltd are some of the leading companies operating in the North America enteral nutrition market.
Summary Info
Industry: | |
---|---|
Pricing options: | |
Geographical coverage: | |
Year of Publication: |
According to the Research Team’ research, the North America enteral nutrition market was valued at US$ 3,206.58 million in 2022 and is expected to reach US$ 5,187.48 million by 2030, registering a CAGR of 6.2% from 2022 to 2030. Specific formulations and plant-based nutrition products and increasing prevalence of gastrointestinal diseases are among the critical factors attributed to the North America enteral nutrition market expansion.
There is a surge in the demand for products that help consumers proactively manage their health, especially those focused on specific needs in terms of energy levels, immunity, and disease treatment. Functionality and specific formulations of enteral products do not interfere with the existing treatments of patients. The macro-nutrient and micronutrient formulations of enteral nutrition and their applications vary based on the disease under consideration. Isocaloric enteral nutrition formulation (1 kcal/ml) is generally prescribed to achieve estimated or measured caloric goals, while energy-dense formulae (>1 kcal/ml) are prescribed to increase calorie delivery in patients with gastrointestinal dysfunction.
Standardized enteral nutrition products contain fixed constituents and are designed to meet an average patient’s nutritional requirements, considering different requirements in different age groups. For example, Peptamen Formula (Nestle) is the only peptide-based formula with enzymatically hydrolyzed 100% whey protein that helps overcome tube-feeding intolerance. Such tube-feeding formulas are specialized enteral nutrition products designed to support absorption and overcome tolerance mechanisms in individuals with gastrointestinal disorders.
Further, a surge in the number of people turning to plant-based food triggers the demand for plant-based nutrition products worldwide. People are becoming increasingly intolerant of artificial/synthetically sourced ingredients used in higher numbers, which may lead to adverse reactions. The Innova Consumer Survey 2020 showed that health, diet variety, sustainability, and taste are among the top reasons why people consider plant-based alternatives. Abbott adds that consumers and patients relying on tube feeding are no exception to this trend. The American Medical Association is calling on healthcare facilities to introduce plant-based meal options to improve patients’ health. California, New York, and the District of Columbia, among others, have asked hospitals to make healthy, plant-based meals available to all patients. Companies in the enteral nutrition market anticipate that a growing focus on healthy foods would translate into a preference for healthier nutrition products. As a result, new companies such as Kate Farms, Functional Formularies, and Real Food Blends have developed more natural, plant-based enteral products. In August 2021, Kate Farms launched the first closed feeding system delivering plant-based formulas in ready-to-hang bags of 1 L capacity. Kate Farms Standard 1.4 plain and Peptide 1.5 plain formulations are plant-based, organic, calorically dense products that are used as a sole source of supplemental nutrition in tube feeding. In September 2021, Abbott introduced a portfolio of plant-based proteins and organic food ingredients for children and adults.
Therefore, functional, patient-centric formulations and plant-based nutrition products are the prime emerging trends in the enteral nutrition market.
On the contrary, complications associated with enteral feeding systems hampers the growth North America enteral nutrition market.
Based on product type, the North America enteral nutrition market is bifurcated into general and disease specific. The general segment held 57.3% share of the North America enteral nutrition market in 2022, amassing US$ 1,837.14 million. It is projected to garner US$ 2,951.22 million by 2030 to expand at 6.1% CAGR during 2022-2030.
In terms of application, the North America enteral nutrition market is segmented into gastrointestinal disorders, metabolic/inborn errors of metabolism, food allergy, renal disease, liver disease, oncology, neurology, and others. The gastrointestinal disorders segment held 30.3% share of the North America enteral nutrition market in 2022, amassing US$ 970.02 million. It is projected to garner US$ 1,557.36 million by 2030 to expand at 6.1% CAGR during 2022-2030.
Based on age group, the North America enteral nutrition market is bifurcated into adult and pediatric. The adult segment held 85.0% share of the North America enteral nutrition market in 2022, amassing US$ 2,725.86 million. It is projected to garner US$ 4,359.92 million by 2030 to expand at 6.0% CAGR during 2022-2030.
By distribution channel, the North America enteral nutrition market is segmented into hospital pharmacies, retail stores, e-commerce, and others. The hospital pharmacies segment held 57.9% share of North America enteral nutrition market in 2022, amassing US$ 1,856.77 million. It is projected to garner US$ 2,953.10 million by 2030 to expand at 6.0% CAGR during 2022-2030.
Based on country, the North America enteral nutrition market is categorized into the US, Canada, and Mexico. The US held 83.4% share of North America enteral nutrition market in 2022, amassing US$ 2,674.29 million. It is projected to garner US$ 4,370.23 million by 2030 to expand at 6.3% CAGR during 2022-2030.
Key players operating in the North America enteral nutrition market are Abbott Laboratories, Nestle SA, Danone SA, Fresenius SE & Co KGaA, B Braun SE, Dr Schar AG, Reckitt Benckiser Group Plc, Nutritional Medicinals LLC, Kate Farms Inc, Royal FrieslandCampina NV, Arla Foods amba, Perrigo Co Plc, and Fonterra Co-Operative Group Ltd, among others.
In Nov 2021, Fonterra and VitaKey Inc. announced a transformative dairy science collaboration to further unlock the benefits of Fonterra’s probiotic strains. VitaKey specializes in precision delivery of nutrition – an emerging area of research that seeks to deliver the right nutrients, in the right amount, to the right part of the body at the right time.
In July 2023, Fonterra announced a new corporate ventures arm to incubate, scale and invest in ventures in the area of nutrition science.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the North America enteral nutrition market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth North America market trends and outlook coupled with the factors driving the enteral nutrition market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution
TABLE OF CONTENTS
1. Introduction
1.1 the Research Team Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Enteral Nutrition Market – Key Industry Dynamics
4.1 Key Market Drivers:
4.1.1 Increasing Prevalence of Gastrointestinal Diseases
4.1.2 Rising Cases of Malnutrition and Premature Births
4.2 Market Restraints
4.2.1 Complications Associated with Enteral Feeding Systems
4.3 Market Opportunities
4.3.1 Strategic Initiatives by Key Market Players
4.4 Future Trends
4.4.1 Specific Formulations and Plant-Based Nutrition Products
4.5 Impact Analysis
5. Enteral Nutrition Market – North America Market Analysis
5.1 North America Enteral Nutrition Market Revenue (US$ million), 2022 – 2030
6. North America Enteral Nutrition Market – Revenue and Forecast to 2030 – by Product Type
6.1 Overview
6.2 North America Enteral Nutrition Market Revenue Share, by Product Type 2022 & 2030 (%)
6.3 General
6.3.1 Overview
6.3.2 General: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
6.3.2.1 North America Enteral Nutrition Market, by General
6.3.2.1.1 North America Enteral Nutrition Market, by Elemental Formula
6.4 Disease Specific
6.4.1 Overview
6.4.2 Disease Specific: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
7. North America Enteral Nutrition Market – Revenue and Forecast to 2030 – by Application
7.1 Overview
7.2 North America Enteral Nutrition Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Gastrointestinal Disorder
7.3.1 Overview
7.3.2 Gastrointestinal Disorder: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Metabolic/Inborn Errors of Metabolism
7.4.1 Overview
7.4.2 Metabolic/Inborn Errors of Metabolism: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Allergy
7.5.1 Overview
7.5.2 Allergy: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Renal Disease
7.6.1 Overview
7.6.2 Renal Disease: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
7.7 Liver Disease
7.7.1 Overview
7.7.2 Liver Disease: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
7.8 Oncology
7.8.1 Overview
7.8.2 Oncology: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
7.9 Neurology
7.9.1 Overview
7.9.2 Neurology: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
7.10 Others
7.10.1 Overview
7.10.2 Others: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8. North America Enteral Nutrition Market – Revenue and Forecast to 2030 – by Age Group
8.1 Overview
8.2 North America Enteral Nutrition Market Revenue Share, by Age Group 2022 & 2030 (%)
8.3 Adult
8.3.1 Overview
8.3.2 Adult: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Pediatric
8.4.1 Overview
8.4.2 Pediatric: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Enteral Nutrition Market – Revenue and Forecast to 2030 – by Distribution Channel
9.1 Overview
9.2 North America Enteral Nutrition Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
9.3 Hospital Pharmacies
9.3.1 Overview
9.3.2 Hospital Pharmacies: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Retail Stores
9.4.1 Overview
9.4.2 Retail Stores: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.5 E-Commerce
9.5.1 Overview
9.5.2 E-Commerce: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
10. North America Enteral Nutrition Market – Country Analysis
10.1 North America Enteral Nutrition Market, Revenue and Forecast To 2030
10.1.1 North America Enteral Nutrition Market, by Country
10.1.1.1 US
10.1.1.1.1 Overview
10.1.1.1.2 US Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
10.1.1.1.3 US Enteral Nutrition Market, by Product Type
10.1.1.1.3.1 US Enteral Nutrition Market, by General
10.1.1.1.3.1.1 US Enteral Nutrition Market, by Elemental Formula
10.1.1.1.4 US Enteral Nutrition Market, by Application
10.1.1.1.5 US Enteral Nutrition Market, by Age Group
10.1.1.1.6 US Enteral Nutrition Market, by Distribution Channel
10.1.1.2 Canada
10.1.1.2.1 Overview
10.1.1.2.2 Canada Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
10.1.1.2.3 Canada Enteral Nutrition Market, by Product Type
10.1.1.2.3.1 Canada Enteral Nutrition Market, by General
10.1.1.2.3.1.1 Canada Enteral Nutrition Market, by Elemental Formula
10.1.1.2.4 Canada Enteral Nutrition Market, by Application
10.1.1.2.5 Canada Enteral Nutrition Market, by Age Group
10.1.1.2.6 Canada Enteral Nutrition Market, by Distribution Channel
10.1.1.3 Mexico
10.1.1.3.1 Overview
10.1.1.3.2 Mexico Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
10.1.1.3.3 Mexico Enteral Nutrition Market, by Product Type
10.1.1.3.3.1 Mexico Enteral Nutrition Market, by General
10.1.1.3.3.1.1 Mexico Enteral Nutrition Market, by Elemental Formula
10.1.1.3.4 Mexico Enteral Nutrition Market, by Application
10.1.1.3.5 Mexico Enteral Nutrition Market, by Age Group
10.1.1.3.6 Mexico Enteral Nutrition Market, by Distribution Channel
11. Enteral Nutrition Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Enteral Nutrition Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Nestle SA
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Danone SA
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Fresenius SE & Co KGaA
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 B Braun SE
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Dr Schar AG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Reckitt Benckiser Group Plc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Nutritional Medicinals LLC
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Kate Farms Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Royal FrieslandCampina NV
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Arla Foods amba
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 Perrigo Co Plc
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
12.13 Fonterra Co-Operative Group Ltd
12.13.1 Key Facts
12.13.2 Business Description
12.13.3 Products and Services
12.13.4 Financial Overview
12.13.5 SWOT Analysis
12.13.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Enteral Nutrition Market Segmentation
Table 2. North America Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – General
Table 3. North America Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Elemental Formula
Table 4. US Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Product Type
Table 5. US Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – General
Table 6. US Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Elemental Formula
Table 7. US Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Application
Table 8. US Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Age Group
Table 9. US Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Distribution Channel
Table 10. Canada Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Product Type
Table 11. Canada Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – General
Table 12. Canada Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Elemental Formula
Table 13. Canada Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Application
Table 14. Canada Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Age Group
Table 15. Canada Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Distribution Channel
Table 16. Mexico Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Product Type
Table 17. Mexico Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – General
Table 18. Mexico Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Elemental Formula
Table 19. Mexico Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) – Application
Table 20. Mexico Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Age Group
Table 21. Mexico Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) – Distribution Channel
Table 22. Recent Inorganic Growth Strategies in the Enteral Nutrition Market
Table 23. Recent Organic Growth Strategies in the Enteral Nutrition Market
Table 24. Glossary of Terms, Enteral Nutrition Market
LIST OF FIGURES
Figure 1. North America Enteral Nutrition Market Segmentation, By Country
Figure 2. North America Enteral Nutrition Market – Key Industry Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. North America Enteral Nutrition Market Revenue (US$ million), 2020 – 2030
Figure 5. North America Enteral Nutrition Market Revenue Share, by Product Type 2022 & 2030 (%)
Figure 6. General: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Disease Specific: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. North America Enteral Nutrition Market Revenue Share, by Application 2022 & 2030 (%)
Figure 9. Gastrointestinal Disorder: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Metabolic/Inborn Errors of Metabolism: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Allergy: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Renal Disease: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Liver Disease: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Oncology: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Neurology: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Others: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. North America Enteral Nutrition Market Revenue Share, by Age Group 2022 & 2030 (%)
Figure 18. Adult: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Pediatric: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. North America Enteral Nutrition Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
Figure 21. Hospital Pharmacies: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Retail Stores: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. E-Commerce: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: North America Enteral Nutrition Market – Revenue and Forecast to 2030 (US$ Million)
Figure 25. North America Enteral Nutrition Market, 2022 (US$ million)
Figure 26. North America Enteral Nutrition Market, By Key Countries, 2022 and 2030 (%)
Figure 27. US Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
Figure 28. Canada Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
Figure 29. Mexico Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
Figure 30. Growth Strategies in the Enteral Nutrition Market
The List of Companies – North America Enteral Nutrition Market
1. Abbott Laboratories
2. Arla Foods amba
3. B Braun SE
4. Danone SA
5. Dr Schar AG
6. Fonterra Co-Operative Group Ltd
7. Fresenius SE & Co KGaA
8. Kate Farms Inc
9. Nestle SA
10. Nutritional Medicinals LLC
11. Perrigo Co Plc
12. Reckitt Benckiser Group Plc
13. Royal FrieslandCampina NV
You must be logged in to post a review.
Reviews
There are no reviews yet.